GAP Applauds Johnson and Johnson’s Foray into Alzheimer’s Vaccine
We thank J&J for their leadership as they announced new efforts to combat Alzheimer’s disease, specifically their vaccine trial. In taking on this tau antibody and a tau-targeting vaccine, J&J is bringing hope to those impacted by Alzheimer’s disease, and addressing the need for cutting-edge research by launching this exciting trial. We are grateful for […]